Literature DB >> 35399891

Pure endoscopic management of a middle fossa Galassi III arachnoid cyst.

Alejandro Vargas-Moreno1, Oscar Gutierrez2, Rene Alvarez-Berastegui2.   

Abstract

Background: Microsurgical and endoscopic approaches are accepted alternatives for the management of symptomatic arachnoid cyst. However, given their ability to visualize critical neurovascular structures with less morbidity, less dissection needs, and high success rates, endoscopic approaches are excellent options for the management of this pathology. Case Description: We present the case of an otherwise healthy 8-year-old male who presented with a chronic history of disabling headache that augmented with exercise and interrupted his sleep. He had a normal neurological examination. Neuroimaging studies depicted a right middle fossa Galassi III arachnoid cyst with no associated hydrocephalus, marked displacement of adjacent cortex, and apparent connection with the basal cisterns. Given the severity of the symptoms, and the size and compressive effect of the arachnoid cyst, surgical management through and endoscopic approach was undertaken. We performed a right temporal burr hole, right above the zygomatic arch to avoid vessels of the Sylvian fissure and to allow an optimal trajectory to the medial edge of the cyst and the target cisterns. We proceeded to identify the endoscopic anatomy of the surrounding structures to perform and adequate fenestration of multiple arachnoid membranes, obtaining an adequate cystocisternal communication. We then performed closure in a standard fashion. The patient was neurologically unchanged after the procedure and was discharged on postoperative day 2. The postoperative images revealed a dramatic reduction in the cyst dimensions with resolution of its compressive effect.
Conclusion: Endoscopic management of arachnoid cyst offers several advantages such as the visualization of the cyst boundaries and critical adjacent structures, and the need for a less extensive dissection having a success rate between 83% and 92%. It is important to perform a wide multifocal fenestration as a key step to avoid cyst reclosure. Copyright:
© 2022 Surgical Neurology International.

Entities:  

Keywords:  Arachnoyd cyst; Endoscopic; Pediatric

Year:  2022        PMID: 35399891      PMCID: PMC8986635          DOI: 10.25259/SNI_80_2022

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


[Video 1]-Available on:

www.surgicalneurologyint.com

Annotations[1-6]

00:00–00:22 – Clinical presentation 00:22–00:37 – Preoperative imaging 00:37–00:51 – Rationale of treatment 00:51–1:51 – Patient positioning and procedure explanation 1:51–2:35 – Endoscopic middle fossa anatomy description 2:35–5:15 – Procedure video 5:15–5:30 – Postoperative imaging and outcome 5:30 – Discussion.
  5 in total

1.  Endoscopic management of intracranial cysts.

Authors:  Jeffrey P Greenfield; Mark M Souweidane
Journal:  Neurosurg Focus       Date:  2005-12-15       Impact factor: 4.047

2.  Endoscopic treatment of arachnoid cysts: a detailed account of surgical techniques and results.

Authors:  Joachim M K Oertel; Wolfgang Wagner; Yvonne Mondorf; Joerg Baldauf; Henry W S Schroeder; Michael R Gaab
Journal:  Neurosurgery       Date:  2010-09       Impact factor: 4.654

3.  Endoscopic treatment of middle fossa arachnoid cysts.

Authors:  Waleed A Azab; Mohamed Almanabri; Waleed Yosef
Journal:  Acta Neurochir (Wien)       Date:  2017-09-13       Impact factor: 2.216

4.  Endoscopic Treatment of Temporal Arachnoid Cysts in 34 Patients.

Authors:  Tim Couvreur; Giorgio Hallaert; Tatjana Van Der Heggen; Edward Baert; Frank Dewaele; Jean-Pierre Kalala Okito; Dimitri Vanhauwaert; Marc Deruytter; Dirk Van Roost; Jacques Caemaert
Journal:  World Neurosurg       Date:  2015-05-09       Impact factor: 2.104

5.  Microsurgical and endoscopic anatomy of the supratentorial arachnoidal membranes and cisterns.

Authors:  Kohei Inoue; Askin Seker; Shigeyuki Osawa; Luis Felipe Alencastro; Toshio Matsushima; Albert L Rhoton
Journal:  Neurosurgery       Date:  2009-10       Impact factor: 4.654

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.